![[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]](https://cddf.org/wp-content/uploads/2026/02/202602_INNOVATIVE-ONCOLOGY-TRIAL-DESIGNS_TIME-TO-ACT-400x250.jpg)
[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]
While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.” This paper was largely...
Key Takeaways of the CDDF ACT-EU Webinar Series
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent ACT-EU webinar series, “Collaborating with stakeholders to define priorities for clinical trials and working collectively to address them.” The first session was held on 15...
Key Takeaways of the CDDF Webinar : “Long-Term Outcomes of In-Utero Exposure to Cytotoxic Therapy.”
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent webinar, "Long-term outcomes of in-utero exposure to cytotoxic therapy." This webinar was held on 4 December 2025 and featured insightful presentations from speakers Agnes...
Executive Summary: Multi-Stakeholder Workshop on “Enabling Smarter Clinical Trials to Optimise Patient Care” (17-18 Nov 2025)
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of its latest multi-stakeholder workshop, "Enabling Smarter Clinical Trials to Optimise Patient Care," has been published today and is available to all our stakeholders. The...
Key Takeaways from the CDDF Multi-Stakeholder Workshop on Enabling smarter clinical trials to optimise patient care (17 November – 18 November 2025)
The first day of the CDDF Multi-Stakeholder Workshop on Enabling smarter clinical trials to optimise patient care Deploying data to design and deliver better trials 17 – 18 November 2025, Hybrid Workshop – Brussels, BE set the stage for insightful discussions on the...
Key Takeaways of CDDF Webinar : “Transformation of future clinical trials using AI-enhanced imaging biomarkers”
The Cancer Drug Development Forum (CDDF) is pleased to present key takeaways of our live webinar series on “AI and Big Data in Cancer Drug Development.” This series is designed to explore the transformative impact of artificial intelligence and big data on oncology....
ACT EU:Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making
ACT EU is pleased to announce a hybrid workshop on 3 November 2025: “Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making” Registration: Please register via the ACT EU website here: Workshop Registration The Methodology...
NEW PUBLICATION – WHITE PAPER: Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action.
The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper - “Overcoming the Barriers to Treatment of Rare Cancer”- has been published, following its “Innovation and Access in Rare Cancers” hybrid workshop held on 23-24 September 2024 in...
NEW PUBLICATION – WHITE PAPER: Dose Optimization in Cancer Drug Development – Review and Outcome of a Multi-Stakeholder Workshop
The Cancer Drug Development Forum (CDDF) is pleased to announce the release of a White Paper developed following the multi-stakeholder workshop “Dose Optimization in Cancer Drug Development,” held on 3–4 April 2023 in Amsterdam, the Netherlands, as a hybrid event....